Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
BIA Separations
BIA Separations
Activities:
Manufacturing
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Distribution
BIA Separations signs two new distribution agreements extending coverage in Asia Pacific
GeneX India Biosciences has taken over sole distribution activities in India, while IT Technologies will operate in Singapore and Malaysia
Manufacturing
BIA to commercialise novel elution method for viral vector purification
University of Zagreb in Coratia has signed an agreement to commercialise new method that helps preserve viruses during immunoaffinity purification
Research & Development
AveXis chooses BIA Separations to support gene therapy pipeline
BIA Separations will provide the Novartis company expertise in next-gen biomolecule purification processes and CIMmultus monolithic columns
Manufacturing
BIA Separations builds new upstream processing facility
The expansion will provide a single source of expertise for scaled up production of complex biologics for gene therapy and vaccines
Manufacturing
Conference to showcase UK strength in medicines manufacturing
GlaxoSmithKline will open its doors at its site in Stevenage, to host the Medicines Manufacturing Industry Partnership Annual Conference 2018, taking place 7 June
Manufacturing
BIA Separations and Biomay collaborate on production and purification of large DNA plasmids
The collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application
Manufacturing
BIA Separations and Nuvonis Technologies partner
The agreement between the two companies will aim to strengthen upstream and downstream process development in vaccine and gene therapy production
Subscribe now